A carregar...
Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis
BACKGROUND: Zoledronic acid is a potent inhibitor of osteoclast-mediated bone resorption and has been widely used in bone metastasis malignancies and postmenopausal osteoporosis as a preventive therapy against skeletal-related events. The purpose of this study was to evaluate the clinical outcome of...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3874690/ https://ncbi.nlm.nih.gov/pubmed/24283946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-80 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|